As you know we are consultees on the upcoming NICE appraisal of bosutinib in previously treated CML.
NICE allows us to nominate a 'patient expert' who will be invited to provide a written personal statement to inform the appraisal committee's consideration of bosutinib as a treatment for CML.
We are looking for a member of this forum based and treated in the UK, who is currently treated with bosutinib and willing to act as a patient expert on this NICE STA.
The deadline for registering as a patient expert is 1st February and you will need to confirm that you can attend the committee hearing on 13th June 2013. NICE will cover all expenses.
Please contact me on cmlsupportgroup@gmail.com
Thanks,
Sandy